227 related articles for article (PubMed ID: 30396880)
41. Successful Management of Severe Hypercalcemia with Zoledronic Acid: A Report of Two Pediatric Cases.
Kilci F; Jones JH; Çizmecioğlu-Jones FM
J Clin Res Pediatr Endocrinol; 2024 May; 16(2):224-228. PubMed ID: 36264042
[TBL] [Abstract][Full Text] [Related]
42. Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome.
Baştuğ F; Nalçacıoğlu H; Baş VN; Tekatlı-Çelik B; Çetinkaya H; Yel S
Turk J Pediatr; 2018; 60(2):210-215. PubMed ID: 30325132
[TBL] [Abstract][Full Text] [Related]
43. Multiple renal calculi due to hypercalcaemia induced by over-the-counter vitamin D intoxication.
Manappallil RG; Shylendran S; Kakkattil A; Thomas AD
BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30131404
[TBL] [Abstract][Full Text] [Related]
44. Pamidronate treatment in acute vitamin D intoxication.
Gurkan F; Davutoglu M; Bosnak M; Ece A; Dikici B; Bilici M; Haspolat K
J Endocrinol Invest; 2004; 27(7):680-2. PubMed ID: 15505994
[TBL] [Abstract][Full Text] [Related]
45. Open-label study of treatment with alendronate sodium plus vitamin D in men and women with osteoporosis in Thailand.
Songpatanasilp T; Rojanasthien S; Sugkraroek P; Ongphiphadhanakul B; Robert L; Robert CS; Luevitoonvechkij S; Santora AC
BMC Musculoskelet Disord; 2018 Nov; 19(1):392. PubMed ID: 30400864
[TBL] [Abstract][Full Text] [Related]
46. Humoral hypercalcemia of pregnancy treated with bisphosphonates.
Koren R; Neeman O; Koren S; Benbassat CA
Arch Endocrinol Metab; 2018 Feb; 62(1):125-128. PubMed ID: 29694631
[TBL] [Abstract][Full Text] [Related]
47. Comparison of 300,000 and 600,000 IU Oral Vitamin-D Bolus for Vitamin-D Deficiency in Young Children.
Harnot J; Verma S; Singhi S; Sankhyan N; Sachdeva N; Bharti B
Indian J Pediatr; 2017 Feb; 84(2):111-116. PubMed ID: 27683282
[TBL] [Abstract][Full Text] [Related]
48. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial.
Gallagher JC; Sai A; Templin T; Smith L
Ann Intern Med; 2012 Mar; 156(6):425-37. PubMed ID: 22431675
[TBL] [Abstract][Full Text] [Related]
49. Unusually prolonged vitamin D intoxication after discontinuation of vitamin D: possible role of primary hyperparathyroidism.
Taskapan H; Vieth R; Oreopoulos DG
Int Urol Nephrol; 2008; 40(3):801-5. PubMed ID: 18528779
[TBL] [Abstract][Full Text] [Related]
50. Oral bisphosphonate therapy for vitamin D intoxication of the infant.
Bereket A; Erdogan T
Pediatrics; 2003 Apr; 111(4 Pt 1):899-901. PubMed ID: 12671131
[TBL] [Abstract][Full Text] [Related]
51. Comparison of low and high dose of vitamin D treatment in nutritional vitamin D deficiency rickets.
Cesur Y; Caksen H; Gündem A; Kirimi E; Odabaş D
J Pediatr Endocrinol Metab; 2003; 16(8):1105-9. PubMed ID: 14594170
[TBL] [Abstract][Full Text] [Related]
52. Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D.
Chandler PD; Scott JB; Drake BF; Ng K; Forman JP; Chan AT; Bennett GG; Hollis BW; Giovannucci EL; Emmons KM; Fuchs CS
Am J Med; 2014 Aug; 127(8):772-8. PubMed ID: 24657333
[TBL] [Abstract][Full Text] [Related]
53. Vitamin A and Hydrochlorothiazide Causing Severe Hypercalcemia in a Patient With Primary Hyperparathyroidism.
Varghese RT; Khasawneh K; Desikan RK; Subramaniam A; Weaver T; Nair GKV
J Investig Med High Impact Case Rep; 2019; 7():2324709618823805. PubMed ID: 30791717
[TBL] [Abstract][Full Text] [Related]
54. Weekly regimen of vitamin D supplementation is more efficacious than stoss regimen for treatment of vitamin D deficiency in children with chronic liver diseases.
Lal BB; Alam S; Khanna R; Rawat D
Eur J Pediatr; 2018 Jun; 177(6):827-834. PubMed ID: 29504044
[TBL] [Abstract][Full Text] [Related]
55. Nephrocalcinosis in children who received high-dose vitamin D.
Lin TH; Lu HJ; Lin CH; Lee MD; Chang BP; Lin CC; Tsai JD
Pediatr Nephrol; 2022 Oct; 37(10):2471-2478. PubMed ID: 35352189
[TBL] [Abstract][Full Text] [Related]
56. Severe hypercalcemia of an infant due to vitamin D toxicity associated with hypercholesterolemia.
Evliyaoğlu O; Berberoğlu M; Ocal G; Adiyaman P; Aycan Z
J Pediatr Endocrinol Metab; 2001; 14(7):915-9. PubMed ID: 11515734
[TBL] [Abstract][Full Text] [Related]
57. Treatment options for hypercalcemia after cosmetic oil injections: Lessons from human tissue cultures and a pilot intervention study.
Yahyavi SK; Theilade S; Hansen D; Berg JO; Andreassen CH; Lorenzen M; Jørgensen A; Juul A; Faber J; Eldrup E; Blomberg Jensen M
Bone; 2022 Jan; 154():116244. PubMed ID: 34757214
[TBL] [Abstract][Full Text] [Related]
58. Vitamin D Toxicity from an Unusual and Unexpected Source: A Report of 2 Cases.
Silva C; Fung AWS; Masson V; Assen K; Ward V; McKenzie J; Blydt-Hansen TD; Cosme J; van der Gugten G; Barakauskas VE; Fox DA
Horm Res Paediatr; 2023; 96(3):332-340. PubMed ID: 36030768
[TBL] [Abstract][Full Text] [Related]
59. Can adverse effects of excessive vitamin D supplementation occur without developing hypervitaminosis D?
Razzaque MS
J Steroid Biochem Mol Biol; 2018 Jun; 180():81-86. PubMed ID: 28734988
[TBL] [Abstract][Full Text] [Related]
60. Severe hypercalcemia following vitamin d supplementation in a patient with multiple sclerosis: a note of caution.
Marcus JF; Shalev SM; Harris CA; Goodin DS; Josephson SA
Arch Neurol; 2012 Jan; 69(1):129-32. PubMed ID: 22232355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
